Lv41
410 积分 2025-08-13 加入
Treatment sequencing using the dual amylin and calcitonin receptor agonist KBP-336 and semaglutide results in durable weight loss
1个月前
已完结
Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial
1个月前
已完结
Design, synthesis and preclinical evaluation of bio-conjugated amylinomimetic peptides as long-acting amylin receptor agonists
1个月前
已完结
Cagrilintide-Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes
1个月前
已完结
Amylin analogs for the treatment of obesity without diabetes: present and future
1个月前
已完结
皖公网安备34019202002308
